Claus G Roehrborn Selected Research

alfuzosin (UroXatral)

1/2008	Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.
4/2006	Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
1/2005	Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
3/2004	Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.
11/2003	First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claus G Roehrborn Research Topics

Disease

112	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 06/2002
79	Lower Urinary Tract Symptoms 01/2022 - 07/2002
64	Prostatic Neoplasms (Prostate Cancer) 06/2021 - 01/2002
32	Neoplasms (Cancer) 01/2019 - 01/2002
22	Urinary Retention 07/2021 - 06/2002
20	Disease Progression 07/2021 - 01/2003
17	Neoplasm Metastasis (Metastasis) 10/2014 - 03/2004
16	Erectile Dysfunction 07/2016 - 11/2003
10	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 05/2006
10	Margins of Excision 12/2016 - 03/2004
8	Nocturia 06/2021 - 08/2006
6	Urinary Incontinence 01/2022 - 12/2003
6	Extranodal Extension 01/2019 - 06/2004
6	Adenocarcinoma 11/2008 - 06/2003
5	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 10/2021 - 11/2003
5	Urinary Bladder Neoplasms (Bladder Cancer) 09/2008 - 01/2002
4	Carcinoma (Carcinomatosis) 01/2019 - 02/2004
4	Inflammation (Inflammations) 11/2016 - 09/2007
4	Lymphatic Metastasis 11/2011 - 02/2004
3	Dizziness (Lightheadedness) 01/2019 - 11/2003
3	Infections 03/2018 - 11/2003
3	Urinary Tract Infections (Urinary Tract Infection) 10/2017 - 12/2003
3	Pain (Aches) 04/2013 - 09/2007
3	Prostatitis 09/2011 - 09/2007
3	Shock 04/2007 - 04/2002
3	Transitional Cell Carcinoma 09/2006 - 01/2002
2	Atrophy 01/2022 - 07/2017
2	Body Weight (Weight, Body) 12/2021 - 12/2006
2	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2017 - 03/2013
2	Ejaculatory Dysfunction 01/2017 - 10/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2016 - 11/2003
2	Constipation 06/2012 - 05/2006
2	Wounds and Injuries (Trauma) 09/2008 - 04/2007
2	Hypertension (High Blood Pressure) 10/2007 - 11/2003
2	Hypotension (Low Blood Pressure) 04/2007 - 03/2004
2	Renal Insufficiency (Renal Failure) 01/2006 - 12/2003
1	Obstructive Sleep Apnea 01/2022
1	Retrograde Ejaculation 01/2022

Drug/Important Bio-Agent (IBA)

41	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 01/2002
35	Dutasteride (Avodart)FDA Link 07/2021 - 09/2002
23	Finasteride (Propecia)FDA LinkGeneric 08/2016 - 06/2002
22	Tamsulosin (Flomax)FDA LinkGeneric 07/2021 - 11/2006
16	Tadalafil (Cialis)FDA Link 07/2016 - 04/2007
11	Testosterone (Sustanon)FDA Link 07/2017 - 11/2003
10	Pharmaceutical PreparationsIBA 01/2022 - 11/2003
7	SteamIBA 09/2021 - 01/2016
6	AndrogensIBA 08/2013 - 01/2002
6	Phosphodiesterase 5 InhibitorsIBA 05/2012 - 01/2008
6	Tolterodine Tartrate (Detrol)FDA Link 02/2009 - 05/2006
6	Doxazosin (Cardura)FDA LinkGeneric 09/2008 - 12/2003
6	Biomarkers (Surrogate Marker)IBA 06/2008 - 11/2005
5	Muscarinic AntagonistsIBA 06/2012 - 04/2006
5	alfuzosin (UroXatral)FDA Link 01/2008 - 11/2003
4	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2008
4	Interleukin-6 (Interleukin 6)IBA 11/2011 - 04/2008
4	EndoglinIBA 06/2009 - 03/2008
3	5-alpha Reductase InhibitorsIBA 01/2022 - 04/2014
3	silodosin FDA Link 01/2021 - 01/2011
3	saw palmetto extractIBA 03/2013 - 08/2006
3	PlasminogenIBA 06/2009 - 02/2007
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2009 - 02/2007
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2009 - 04/2008
3	alpha Adrenergic ReceptorsIBA 01/2009 - 12/2003
3	nuclear matrix protein 22IBA 02/2008 - 05/2005
3	SurvivinIBA 02/2007 - 02/2004
2	Parasympatholytics (Antispasmodics)IBA 01/2022 - 10/2009
2	fesoterodine FDA Link 01/2022 - 06/2012
2	salicylhydroxamic acid (SHAM)IBA 09/2021 - 06/2017
2	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2019 - 01/2018
2	Hormones (Hormone)IBA 01/2018 - 06/2014
2	Biological ProductsIBA 02/2015 - 03/2004
2	Proteins (Proteins, Gene)FDA Link 04/2013 - 05/2007
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2011 - 06/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2011 - 03/2011
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 10/2011 - 03/2011
2	Urokinase Plasminogen Activator ReceptorsIBA 06/2009 - 02/2007
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2009 - 06/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2009 - 06/2008
2	EnzymesIBA 06/2009 - 06/2008
2	Plasminogen Activators (Plasminogen Activator)IBA 06/2009 - 06/2008
2	DioxinsIBA 11/2006 - 07/2006
2	Dihydrotestosterone (Androstanolone)IBA 04/2006 - 09/2002
1	Solifenacin Succinate FDA Link 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	imidafenacinIBA 01/2022
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 01/2022
1	oxybutynin (Tavor)FDA LinkGeneric 01/2022
1	indolepropanol phosphate (IPP)IBA 12/2021

Therapy/Procedure

62	Therapeutics 01/2022 - 01/2002
37	Prostatectomy (Retropubic Prostatectomy) 12/2021 - 06/2003
14	Radiotherapy 06/2014 - 06/2003
8	Lymph Node Excision (Lymph Node Dissection) 11/2008 - 02/2007
7	Transurethral Resection of Prostate (TURP) 01/2022 - 01/2008
7	Chemoprevention 06/2021 - 03/2004
7	Aftercare (After-Treatment) 01/2018 - 01/2002
4	Catheters 01/2018 - 01/2005
2	Drug Therapy (Chemotherapy) 09/2008 - 01/2005
2	Operative Surgical Procedures 01/2008 - 11/2004
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 11/2004 - 04/2002
1	Precision Medicine 01/2022